2018 update of the EULAR recommendations for the management of Behçet’s syndrome

Gulen Hatemi, Robin Christensen, Dongsik Bang, Bahram Bodaghi, Aykut Ferhat Celik, Farida Fortune, Julien Gaudric, Ahmet Gul, Ina Kötter, Pietro Leccese, Alfred Mahr, Robert Moots, Yesim Ozguler, Jutta Richter, David Saadoun, Carlo Salvarani, Francesco Scuderi, Petros P Sfikakis, Aksel Siva, Miles Stanford, Ilknur Tugal-Tutkun, Richard West, Sebahattin Yurdakul, Ignazio Olivieri, Hasan Yazici

10.1136/annrheumdis-2018-213225

April 6, 2018

EULAR recommendations for the health professional’s approach to pain management in inflammatory arthritis and osteoarthritis

Rinie Geenen, Cécile L Overman, Robin Christensen, Pernilla Åsenlöf, Susana Capela, Karen L Huisinga, Mai Elin P Husebø, Albère J A Köke, Zoe Paskins, Irene A Pitsillidou, Carine Savel, Judith Austin, Afton L Hassett, Guy Severijns, Michaela Stoffer-Marx, Johan W S Vlaeyen, César Fernández-de-las-Peñas, Sarah J Ryan, Stefan Bergman

10.1136/annrheumdis-2017-212662

May 3, 2018

Tocilizumab discontinuation after attaining remission in patients with rheumatoid arthritis who were treated with tocilizumab alone or in combination with methotrexate: results from a prospective randomised controlled study (the second year of the SURPRISE study)

Yuko Kaneko, Masaru Kato, Yoshiya Tanaka, Masayuki Inoo, Hitomi Kobayashi-Haraoka, Koichi Amano, Masayuki Miyata, Yohko Murakawa, Hidekara Yasuoka, Shintaro Hirata, Eiichi Tanaka, Nobuyuki Miyasaka, Hisashi Yamanaka, Kazuhiko Yamamoto, Tsutomu Takeuchi, the SURPRISE study group, Takao Fujii, Atsushi Kawakami, Hideshi Yamazaki, Yasuaki Okuda, Kazuhide Tanimura, Atsushi Kaneko, Toshio Tanaka, Akira Murasawa, Kazuhiko Ezawa, Yukitaka Ueki, Yoshiki Shiohira, Hiroaki Dobashi, Naoki Kondo, Toshihiko Hidaka, Hajime Sano, Mitsuhiro Iwahasi, Motohiro Oribe, Shohei Nagaoka, Kensei Tsuzaka

10.1136/annrheumdis-2018-213416

May 31, 2018

EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice

Christian Dejaco, Sofia Ramiro, Christina Duftner, Florent L Besson, Thorsten A Bley, Daniel Blockmans, Elisabeth Brouwer, Marco A Cimmino, Eric Clark, Bhaskar Dasgupta, Andreas P Diamantopoulos, Haner Direskeneli, Annamaria Iagnocco, Thorsten Klink, Lorna Neill, Cristina Ponte, Carlo Salvarani, Riemer H J A Slart, Madeline Whitlock, Wolfgang A Schmidt

10.1136/annrheumdis-2017-212649

January 22, 2018

Editor's choice

Number of individual ACPA reactivities in synovial fluid immune complexes, but not serum anti-CCP2 levels, associate with inflammation and joint destruction in rheumatoid arthritis

Azita Sohrabian, Linda Mathsson-Alm, Monika Hansson, Ann Knight, Jörgen Lysholm, Martin Cornillet, Karl Skriner, Guy Serre, Anders Larsson, Tomas Weitoft, Johan Rönnelid

10.1136/annrheumdis-2017-212627

June 12, 2018

Trimethoprim–sulfamethoxazole prophylaxis prevents severe/life-threatening infections following rituximab in antineutrophil cytoplasm antibody-associated vasculitis

Andreas Kronbichler, Julia Kerschbaum, Seerapani Gopaluni, Joanna Tieu, Federico Alberici, Rachel Bronwen Jones, Rona M Smith, David R W Jayne

10.1136/annrheumdis-2017-212861

June 27, 2018

Exposure to passive smoking and rheumatoid arthritis risk: results from the Swedish EIRA study

Anna Karin Hedström, Lars Klareskog, Lars Alfredsson

10.1136/annrheumdis-2018-212973

May 3, 2018

Editor's choice

Therapeutic innovation in adult-onset Still’s disease (and other rare inflammatory disorders): how to secure evidence-based medicine?

Philippe Guilpain, Alain Le Quellec, Alexandre Thibault Jacques Maria

10.1136/annrheumdis-2018-213106

June 2, 2018

Prediction of autoimmune connective tissue disease in an at-risk cohort: prognostic value of a novel two-score system for interferon status

Md Yuzaiful Md Yusof, Antonios Psarras, Yasser M El-Sherbiny, Elizabeth M A Hensor, Katherine Dutton, Sabih Ul-Hassan, Ahmed S Zayat, Mohammad Shalbaf, Adewonuola Alase, Miriam Wittmann, Paul Emery, Edward M Vital

10.1136/annrheumdis-2018-213386

June 21, 2018

Prophylactic effect of trimethoprim-sulfamethoxazole for pneumocystis pneumonia in patients with rheumatic diseases exposed to prolonged high-dose glucocorticoids

Jun Won Park, Jeffrey R Curtis, Jinyoung Moon, Yeong Wook Song, Suhnggwon Kim, Eun Bong Lee

10.1136/annrheumdis-2017-211796

November 1, 2017